Artelo Biosciences Withdraws Registration Filing
Ticker: ARTL · Form: RW · Filed: Mar 27, 2026 · CIK: 0001621221
Sentiment: neutral
Topics: withdrawal, registration, regulatory
TL;DR
ARTELO BIOSCIENCES WITHDREW A REGISTRATION FILING ON 3/27/2026. WTF?
AI Summary
Artelo Biosciences, Inc. filed a Form RW, a Registration Withdrawal Request, on March 27, 2026. This filing indicates the company is withdrawing a previously filed registration. The specific registration being withdrawn is not detailed in this document.
Why It Matters
This filing suggests a change in Artelo Biosciences' strategy or a correction to a previous filing, potentially impacting future regulatory actions or offerings.
Risk Assessment
Risk Level: medium — Withdrawal of a registration can indicate uncertainty or changes in corporate strategy, which introduces a moderate level of risk.
Key Players & Entities
- Artelo Biosciences, Inc. (company) — Filer of the Form RW
- 0001640334-26-000558 (filing_id) — SEC Accession Number for the Form RW
- 2026-03-27 (date) — Filing Date of the Form RW
FAQ
What specific registration is Artelo Biosciences, Inc. withdrawing?
The provided document does not specify which registration is being withdrawn, only that a Form RW (Registration Withdrawal Request) has been filed.
What is the purpose of a Form RW filing?
A Form RW is a request to withdraw a previously filed registration statement with the SEC.
When was this withdrawal request filed?
The Form RW was filed on March 27, 2026.
What is Artelo Biosciences, Inc.'s CIK number?
Artelo Biosciences, Inc.'s CIK number is 0001621221.
What is the SIC code for Artelo Biosciences, Inc.?
The SIC code for Artelo Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 330 words · 1 min read · ~1 pages · Grade level 9.3 · Accepted 2026-03-27 08:00:24
Filing Documents
- artl_rw.htm (RW) — 8KB
- 0001640334-26-000558.txt ( ) — 9KB
From the Filing
artl_rw.htm Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 March 27, 2026 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Request for Withdrawal Registration Statement on Form S-1 (File No. 333-294506) Ladies and Gentlemen, Pursuant to Rule 477 of the Securities Act of 1933, as amended ("Securities Act"), Artelo Biosciences, Inc. (the "Company") hereby requests the withdrawal of its Registration Statement on Form S-1 (File No. 333-294506), initially filed with the U.S. Securities and Exchange Commission ("SEC") on March 20, 2026, which became effective on March 25, 2026, together with all exhibits thereto (the "Registration Statement"), with such application for withdrawal to be approved effective as of the date first set forth above or at the earliest practical date thereafter. The Company is seeking withdrawal of the Registration Statement as it does not intend to pursue the contemplated offering of the securities covered by the Registration Statement at this time. The Company confirms that no securities of the Company were issued or sold pursuant to the Registration Statement. The Company acknowledges that no refund will be made for fees paid to the SEC in connection with the filing of the Registration Statement. However, in accordance with Rule 457(p) under the Securities Act, the Company requests that all fees paid to the SEC in connection with the filing of the Registration Statement be credited for future use. We would be grateful if you could please send a copy of the written order granting withdrawal of the Registration Statement to Louis A. Bevilacqua of Bevilacqua PLLC via email at lou@bevilacquapllc.com. If you have any further questions regarding this request for withdrawal, or if you require any additional information, please contact Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100 or lou@bevilacquapllc.com. Respectfully, Artelo Biosciences, Inc. By: /s/ Gregory D. Gorgas Gregory D. Gorgas Chief Executive Officer cc: Louis A. Bevilacqua, Esq., Bevilacqua PLLC